NCT06099717 Clinical Performance of Dual-cantilevered Single-implant Bridge
| NCT ID | NCT06099717 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Bern |
| Condition | Dental Implant Failed |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-06-30 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-06-30 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to evaluate the clinical performance (implant and prosthetic survival/ success rates) of a novel implant-supported fixed dental prosthesis design: the dual-cantilevered single implant bridge (T-Bridge) made out of monolithic zirconia bonded to a titanium base abutment (Variobase abutments)
Eligibility Criteria
Inclusion Criteria: * Age ≥ 20 years * Willingness to sign an informed consent and participate in the study * Three missing adjacent teeth in the posterior site. * Tooth gap of 21-24 mm. * Presence of natural or artificial opposing dentition * Sufficient vertical interocclusal space of an implant restoration (7mm) * Sufficient ridge height to place an implant of 10mm in length * Sufficient ridge width for the placement of a 4.1mm diameter implant. Simultaneous GBR to achieve a width of 6.5mm will be included. Exclusion Criteria: * Any physical or mental disorder that would interfere with the ability to perform adequate oral hygiene or the capability of providing written informed consent and compliance with the protocol * Any disorder that would interfere with wound healing or represent a contraindication for implant surgery, such as but not limited to uncontrolled diabetes or conditions resulting in or requiring immunosuppression, radiation, chemotherapy, frequent use of antibiotics or antiresorptive medication such as bisphosphonates. * Pregnancy or lactation * Heavy smoking habit with ≥ 10 cig/d * Severe bruxism or clenching habits, presence of oro-facial pain * Insufficient ridge width/height for the study implant
Contact & Investigator
Martin Schimmel, Prof
STUDY CHAIR
University of Bern
Frequently Asked Questions
Who can join the NCT06099717 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dental Implant Failed. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06099717 currently recruiting?
Yes, NCT06099717 is actively recruiting participants. Contact the research team at manrique.fonseca@unibe.ch for enrollment information.
Where is the NCT06099717 trial being conducted?
This trial is being conducted at Goiânia, Brazil.
Who is sponsoring the NCT06099717 clinical trial?
NCT06099717 is sponsored by University of Bern. The principal investigator is Martin Schimmel, Prof at University of Bern. The trial plans to enroll 50 participants.